Skip to main content

Patient Profiles

Ellie W.
Actual Nurtec ODT patient.

*Per IQVIA as oral brand in class (oral CGRP receptor antagonists): number one prescribed and number one in new prescriptions, since 8/6/21. Data current as of 8/21/23.

Over 995,000 patients have been prescribed Nurtec ODT—real patients like these

Adapt to your patients’ needs, including predictable, unavoidable, and planned triggers1,2

Evan has approximately 4 migraine attacks
per month. He needs an acute treatment
that gets him back to feeling like his normal self.

Evan B. Actual Nurtec ODT patient.
Individual results may vary.

Greg has migraines stemming from traumatic
brain injury and concussions he sustained as
an elite Green Beret. His migraine attacks are
triggered by stress.

Greg P. Actual Nurtec ODT patient.
Individual results may vary.

Ellie averages 4 migraines per month but the
migraines increase when facing unavoidable
like stress.

Ellie W. Actual Nurtec ODT patient.
Individual results may vary.

Jennifer experiences ~10-12 headache days
per month. She wants something oral and
and seeks migraine pain relief to
help her be present every day.

Jennifer F. Actual Nurtec ODT patient.
Individual results may vary.

Patients were invited to share their experiences on Nurtec ODT. All content was accurate at the time of publication.
MOH=medication overuse headache
Per IQVIA NPA-MD, accessed 8/11/23.
The maximum dose of Nurtec ODT in a 24-hour period is 75 mg. The safety of using more than 18 doses of Nurtec ODT in a 30-day period has not been established.1

What real patients are saying about Nurtec ODT

Showing 15 of 69

References: 1. Nurtec ODT. Package insert. Pfizer Inc. 2. Health Union, LLC. Migraine in America 2021. Health Union, LLC; 2020. 3. Ishii R, Schwedt TJ, Trivedi M, et al. Mild traumatic brain injury affects the features of Migraine. J Headache Pain. 2021;22(1). doi:10.1186/s10194-021-01291-x


Helix Image

Welcome to nurtec‑

This website is intended for U.S. healthcare professionals only.

Are you a healthcare professional in the U.S.?

yes no